News
U.S. FDA Approves Gileads Antiviral Veklury (remdesivir) for Treatment of COVID-19
Gilead Sciences, Inc. announced that the U.S. FDA has approved the antiviral drug Veklury® (remdesivir) for the treatment of patients with COVID-19 requiring hospitalization. As an antiviral drug, Veklury works to stop replication of SARS-CoV-2, the virus that causes...
Drug Research
3P Biopharmaceuticals and SpyBiotech enter into a vaccine contract manufacturing agreement
3P Biopharmaceuticals, a leading Contract Development and Manufacturing Organization (CDMO) specialized in process development and cGMP manufacturing of biologics, has signed a manufacturing agreement withSpyBiotech, a company with a novel vaccine platform to target infectious diseases, cancer and chronic...
News
Kamada Ltd, Signs a Supply Agreement with the Israeli Health Authorities for the Investigational Anti-COVID-19 Plasma-Derived Therapy
The Israeli health authorities have signed a supply agreement for the investigational Covid-19 plasma-derived Immunoglobulin (IgG), to be supplied by Kamada Ltd., a biopharmaceutical company which is partnered with Kedrion Biopharma in the development of the new anti-Covid-19 therapy.
The...
News
Covaxin: Bharat Biotech gets nod from DCGI panel for Covid vaccine Phase III trials
The phase 3 trials will be conducted in 19 sites across 10 states, including in cities such as Delhi, Mumbai, Patna and Lucknow and would seek to enroll 28,500 volunteers aged 18 years and above.
Covaxin, the coronavirus vaccine candidate...
News
Lonza Expands Its Capsule Manufacturing Capacity
Lonza announced a CHF85m (93m USD) investment in its Capsules and Health Ingredients (CHI) Division, a dosage form delivery partner to the biopharma and health nutrition industry. The investment will enable the company to expand its overall production capacity...
News
Teknova Completes FDA Notification Process for COVID-19 Transport Media
Teknova, a leading manufacturer of cell culture media and supplements, protein purification buffers, and molecular biology reagents, has completed the United States FDA notification process for its CDC formulation Viral Transport Medium (VTM). Therefore, Teknova Viral Transport Medium is...
News
Recipharm’s proprietary molecule Erdosteine has been positively tested as part of COVID-19 treatment
Recipharm is pleased to announce that the results of the study with Erdosteine as an add-on treatment for COVID-19 patients are now available.
The clinical study involved 20 patients affected by COVID-19 with severe respiratory failure, hospitalized in one of...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.